Bluejay Diagnostics, Inc. Investment Income, Net
Bluejay Diagnostics, Inc. (BJDX) reported Investment Income, Net of $97.56 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-03-06
- Bluejay Diagnostics, Inc. investment income, net for fiscal 2025 was $97.56K, a 33.10% decline from fiscal 2024.
- Bluejay Diagnostics, Inc. investment income, net for fiscal 2024 was $145.82K, a 11.57% decline from fiscal 2023.
- Bluejay Diagnostics, Inc. investment income, net for fiscal 2023 was $164.90K.
| Period end | Investment Income, Net 12 month |
|---|---|
| 2025-12-31 | $97.56K 10-K · filed 2026-03-06 |
| 2024-12-31 | $145.82K 10-K · filed 2026-03-06 |
| 2023-12-31 | $164.90K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |